HomeNewsBusinessCoronavirus pandemic | NSE gives more time to brokers for submission of reports

Coronavirus pandemic | NSE gives more time to brokers for submission of reports

The National Stock Exchange (NSE) has relaxed compliance requirements for brokers to submit reports pertaining to client funding and net worth certificates in the wake of prevailing coronavirus pandemic.

April 09, 2020 / 11:40 IST
Story continues below Advertisement

The National Stock Exchange (NSE) has relaxed compliance requirements for brokers to submit reports pertaining to client funding and net worth certificates in the wake of prevailing coronavirus pandemic.

However, the due date for submitting the quarterly report on the incidence of cyber-attacks and threats will remain unchanged — 15 days after the end of the quarter, NSE said in a circular.

Story continues below Advertisement

The exchange has given time till April 30 to brokers for submitting reports on client funding, artificial intelligence (AI) and machine learning (ML) applications and quarterly compliance certificate.

The due dates for submitting the report on AI and ML applications and quarterly compliance certificate was April 15, while the same for client funding was April 7.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show